These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34218259)

  • 1. Nontuberculous mycobacterial infection and environmental molybdenum in persons with cystic fibrosis: a case-control study in Colorado.
    Lipner EM; Crooks JL; French J; Strong M; Nick JA; Prevots DR
    J Expo Sci Environ Epidemiol; 2022 Mar; 32(2):289-294. PubMed ID: 34218259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010-2019).
    Marshall JE; Mercaldo RA; Lipner EM; Prevots DR
    BMC Infect Dis; 2023 Jul; 23(1):489. PubMed ID: 37488500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program.
    Gross JE; Caceres S; Poch K; Hasan NA; Jia F; Epperson LE; Lipner E; Vang C; Honda JR; Strand M; Calado Nogueira de Moura V; Daley CL; Strong M; Davidson RM; Nick JA
    Am J Respir Crit Care Med; 2022 May; 205(9):1064-1074. PubMed ID: 35085056
    [No Abstract]   [Full Text] [Related]  

  • 4. The risk of pulmonary NTM infections and water-quality constituents among persons with cystic fibrosis in the United States, 2010-2019.
    Lipner EM; French JP; Mercaldo RA; Nelson S; Zelazny AM; Marshall JE; Strong M; Falkinham JO; Prevots DR
    Environ Epidemiol; 2023 Oct; 7(5):e266. PubMed ID: 37840858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nontuberculous Mycobacteria Infection Risk and Trace Metals in Surface Water: A Population-based Ecologic Epidemiologic Study in Oregon.
    Lipner EM; French JP; Falkinham JO; Crooks JL; Mercaldo RA; Henkle E; Prevots DR
    Ann Am Thorac Soc; 2022 Apr; 19(4):543-550. PubMed ID: 34582742
    [No Abstract]   [Full Text] [Related]  

  • 6. Nontuberculous Mycobacterial Disease and Molybdenum in Colorado Watersheds.
    Lipner EM; French J; Bern CR; Walton-Day K; Knox D; Strong M; Prevots DR; Crooks JL
    Int J Environ Res Public Health; 2020 May; 17(11):. PubMed ID: 32485845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.
    Malcolm KC; Wheeler EA; Calhoun K; Lenhart-Pendergrass PM; Rysavy N; Poch KR; Caceres SM; Saavedra MT; Nick JA
    Microbiol Spectr; 2022 Aug; 10(4):e0187422. PubMed ID: 35863022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Geospatial Epidemiologic Analysis of Nontuberculous Mycobacterial Infection: An Ecological Study in Colorado.
    Lipner EM; Knox D; French J; Rudman J; Strong M; Crooks JL
    Ann Am Thorac Soc; 2017 Oct; 14(10):1523-1532. PubMed ID: 28594574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.
    Adjemian J; Olivier KN; Prevots DR
    Ann Am Thorac Soc; 2018 Jul; 15(7):817-826. PubMed ID: 29897781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient Complement Opsonization Impairs Mycobacterium avium Killing by Neutrophils in Cystic Fibrosis.
    Lenhart-Pendergrass PM; Malcolm KC; Wheeler E; Rysavy NM; Poch K; Caceres S; Calhoun KM; Martiniano SL; Nick JA
    Microbiol Spectr; 2023 Feb; 11(1):e0327922. PubMed ID: 36651756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological trends in nontuberculous mycobacterial infection among people with cystic fibrosis in Germany.
    Steindor M; Hafkemeyer S; Ruckes C; Stehling F; Naehrlich L; Ringshausen FC
    Int J Infect Dis; 2023 Apr; 129():32-39. PubMed ID: 36736578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study.
    Martiniano SL; Caceres SM; Poch K; Rysavy NM; Lovell VK; Armantrout E; Jones M; Anthony M; Keck A; Nichols DP; Vandalfsen JM; Sagel SD; Wagner B; Xie J; Weaver K; Heltshe SL; Daley CL; Davidson RM; Nick JA;
    J Cyst Fibros; 2024 Jan; 23(1):50-57. PubMed ID: 37666709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and management of nontuberculous mycobacterial disease in people with cystic fibrosis, the Netherlands.
    Zomer D; van Ingen J; Hofland R;
    J Cyst Fibros; 2023 Mar; 22(2):327-333. PubMed ID: 36347785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.
    Binder AM; Adjemian J; Olivier KN; Prevots DR
    Am J Respir Crit Care Med; 2013 Oct; 188(7):807-12. PubMed ID: 23927602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Clin Chest Med; 2022 Dec; 43(4):697-716. PubMed ID: 36344075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental predictors of pulmonary nontuberculous mycobacteria (NTM) sputum positivity among persons with cystic fibrosis in the state of Florida.
    Foote SL; Lipner EM; Prevots DR; Ricotta EE
    PLoS One; 2021; 16(12):e0259964. PubMed ID: 34882686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (pHALT NTM) study: Rationale and study design.
    Gross JE; Caceres S; Poch K; Epperson LE; Hasan NA; Jia F; Calado Nogueira de Moura V; Strand M; Lipner EM; Honda JR; Strong M; Davidson RM; Daley CL; Nick JA
    PLoS One; 2023; 18(12):e0291910. PubMed ID: 38117792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (HALT NTM) study: Rationale and study design.
    Gross JE; Caceres S; Poch K; Hasan NA; Davidson RM; Epperson LE; Lipner E; Vang C; Honda JR; Strand M; Strong M; Saiman L; Prevots DR; Olivier KN; Nick JA
    PLoS One; 2021; 16(12):e0261628. PubMed ID: 34929010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Epidemiologic Investigation of
    Gross JE; Teneback CC; Sweet JG; Caceres SM; Poch KR; Hasan NA; Jia F; Epperson LE; Lipner EM; Vang CK; Honda JR; Strand MJ; Calado Nogueira de Moura V; Daley CL; Strong M; Davidson RM; Nick JA
    Ann Am Thorac Soc; 2023 May; 20(5):677-686. PubMed ID: 36656594
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mycobacterial lung disease in patients with cystic fibrosis--report of three cases].
    Wyrostkiewicz D; Skorupa W; Jakubowska L; Zabost A; Kuś J
    Pneumonol Alergol Pol; 2014; 82(6):561-7. PubMed ID: 25339567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.